Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 11, 2011, Pages 1477-1483

  Donahue, Amber C ^a   Abdool, Adam K ^a   Gaur, Renu ^a   Wohlgemuth, Jay G ^a   Yeh, Chen Hsiung ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia (AML); FISH; MLPA; Myelodysplastic syndrome (MDS)

Indexed keywords

DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA EXTRACTION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BONE MARROW; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MOLECULAR PROBE TECHNIQUES; MYELODYSPLASTIC SYNDROMES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 80053971614     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.06.019     Document Type: Article

References (20)

1. Potti A., Dressman H.K., Bild A., Riedel R.F., Chan G., Sayer R., et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006, 12(11):1294-1300.
2. Van Bockstaele F., Verhasselt B., Philippe J. Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009, 23(1):25-47.
3. Haferlach T., Kern W., Schnittger S., Schoch C. Modern diagnostics in acute leukemias. Crit Rev Oncol Hematol 2005, 56(2):223-234.
4. Raanani P., Ben-Bassat I. Detection of minimal residual disease in acute myelogenous leukemia. Acta Haematol 2004, 112(1-2):40-54.
5. Malcovati L., Nimer S.D. Myelodysplastic syndromes: diagnosis and staging. Cancer Control 2008, 15(Suppl.):4-13.
6. Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008, 87(7):515-526.
7. Liu Y.C., Ito Y., Hsiao H.H., Sashida G., Kodama A., Ohyashiki J.H., et al. Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited. Cancer Genet Cytogenet 2006, 171(1):9-16.
8. Ma Y., Wang X., Xu X., Lin G. Prognostic value of trisomy 8 in primary myelodysplastic syndrome. Intern Med J 2009.
9. Kearney L., Horsley S.W. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 2005, 114(4):286-294.
10. Alvarez S., Cigudosa J.C. Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005, 23(1):18-25.
11. Panani A.D., Roussos C. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications. Cancer Lett 2006, 235(2):177-190.
12. Huh J., Tiu R.V., Gondek L.P., O'Keefe C.L., Jasek M., Makishima H., et al. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 2010, 49(4):390-399.
13. Starczynowski D.T., Vercauteren S., Telenius A., Sung S., Tohyama K., Brooks-Wilson A., et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood 2008, 112(8):3412-3424.
14. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30(12):e57.
15. den Dunnen J.T., White S.J. MLPA and MAPH: sensitive detection of deletions and duplications. Curr Protoc Hum Genet 2006, [Chapter 7: Unit].
16. Neill N.J., Torchia B.S., Bejjani B.A., Shaffer L.G., Ballif B.C. Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH. Mol Cytogenet 2010, 3:11.
17. Al Zaabi E.A., Fernandez L.A., Sadek I.A., Riddell D.C., Greer W.L. Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience. J Mol Diagn 2010, 12(2):197-203.
18. Buijs A., Krijtenburg P.J., Meijer E. Detection of risk-identifying chromosomal abnormalities and genomic profiling by multiplex ligation-dependent probe amplification in chronic lymphocytic leukemia. Haematologica 2006, 91(10):1434-1435.
19. Coll-Mulet L., Santidrian A.F., Cosialls A.M., Iglesias-Serret D., de F.M., Grau J., et al. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br J Haematol 2008, 142(5):793-801.
20. Stevens-Kroef M., Simons A., Gorissen H., Feuth T., Weghuis D.O., Buijs A., et al. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification. Cancer Genet Cytogenet 2009, 195(2):97-104.